Skip to main content

Darzalex 400 mg/20 mL (20 mg/mL) injection Images

Generic Name: daratumumab

This medication has been identified as Darzalex 400 mg/20 mL (20 mg/mL) injection. It is supplied by Janssen Biotech, Inc.

Darzalex is used in the treatment of Multiple Myeloma and belongs to the drug class CD38 monoclonal antibodies. Darzalex 400 mg/20 mL (20 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Darzalex 400 mg/20 mL (20 mg/mL) injection medicine

Darzalex

Generic Name
daratumumab
Strength
400 mg/20 mL (20 mg/mL) injection
Availability
Prescription only
Drug Class
CD38 monoclonal antibodies
CSA Schedule
Not a controlled drug
Labeler / Supplier
Janssen Biotech, Inc.
National Drug Code (NDC)
57894-0502

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.